Purdue Pharma announced on 6/27/2018 successful completion of a first-in-human Phase 1 dose escalation study of tinostamustine in patients with relapsed or refractory hematological malignancies... read more
Purdue Pharma announced on 6/27/2018 successful completion of a first-in-human Phase 1 dose escalation study of tinostamustine in patients with relapsed or refractory hematological malignancies... read more
After six companies raised approximately $720 million last week four more IPOs are planned this week seeking to raise $500 million plus.
... read more
Kaleido Biosciences, announced on 6/25/2018 that it has closed $101 million in an oversubscribed Series C financing. Several new investors participated in the financing, including a wholly-owned... read more
Arcus Biosciences, Inc. (NYSE:RCUS) and Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) announced on 6/26/2018 that they have entered into a clinical collaboration to evaluate two triple combination... read more
The FDA approved on 6/21/2018 the Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes. This is the first FDA-approved CGM system to... read more